Medtronic Endovascular
Clinical trials sponsored by Medtronic Endovascular, explained in plain language.
Now part of
Medtronic plc
MDT
NYSE
A subsidiary of Medtronic, focused on endovascular devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device for leg clots tested in first human survey Results expected Oct 2026 (estimated)
- New coil survey aims to improve blood vessel treatments Results expected Nov 2026 (estimated)
- Liquid plug could stop bleeding without surgery Results expected Apr 2027 (estimated)